West Pharmaceutical Services, Inc. (WST)
NYSE • Healthcare
Last close at October 2, 2026 at 20:00 UTC
Metrics Over Time
Where the Money Goes
Q2 2026In plain terms: out of every $100 in revenue, West Pharmaceutical Services, Inc. keeps $18 as net profit.
Fundamentals & Financials
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Income Statement
Balance Sheet
Financial Highlights
Dividends History
Split History
Earnings
Oct 22
in 18 daysQ4 2026% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS
West Pharmaceutical Services beat both the top and bottom line in the second fiscal quarter of 2026, with results reported July 23, 2026: adjusted EPS of $2.37 topped the $2.08 estimate by +13.9%, and revenue of about $872.3 million exceeded the $840.0 million consensus by +3.8%. Revenue rose 14% from $766.2 million a year ago, while adjusted EPS increased 29% from $1.84. Net income climbed 17% to about $154.0 million from $131.8 million, and operating income came in at roughly $179.1 million as operating margin held near 21% after gross margin of about 38%. Operating cash flow reached about $124.0 million, and the company paid about $15.7 million in dividends. Next-period consensus calls for EPS of $2.14 on revenue of $820.2 million.
Next report — what to expect
West Pharmaceutical Services, Inc. (WST) reports on October 22, 2026. Wall Street is looking for consensus EPS of $2.18 on consensus revenue of $826.0 million. For trailing context, revenue grew +13.8% year over year last quarter. WST has beaten EPS in 8 of 8 most recent quarters, making expectations and any update to revenue growth a key watch.
About West Pharmaceutical Services, Inc.
West Pharmaceutical Services, Inc. (NYSE: WST) makes containment and delivery products for injectable medicines and related healthcare uses, operating in the medical instruments and supplies business. The company generated $3.1 billion in FY2025 revenue. Its business centers on components for injectable packaging, advanced drug administration systems, and contract-made medical devices.
Today's Snapshot
WST ended the day slightly lower at 364.98, in line with a flat sector.
Trading Volume
Below 10d avg (601.0K)
471.9K
vs S&P 500 Today
Underperforming Market
-0.79%
Updated: October 2, 2026 at 20:21 UTC
Technical Indicators
All signalsHide signals
- EMA (5 indicators)$311.04 - $367.88Buy
- RSI (14)54.20Neutral
- Stochastic %K (14, 3, 3)53.52Neutral
- MACD Level (12, 26)5.90Neutral
Peers & Related Assets
Get premium market insights delivered directly to your inbox.